Intracranial injection of viral vectors engineered to express a fluorescent protein is a versatile labeling technique for visualization of specific subsets of cells in different brain regions both in vivo and in brain sections. Unlike the injection of fluorescent dyes, viral labeling offers targeting of individual cell types and is less expensive and time consuming than establishing transgenic mouse lines. In this technique, an adeno-associated viral (AAV) vector is injected intracranially using stereotaxic coordinates, a micropipette and an automated pump for precise delivery of AAV to the desired area with minimal damage to the surrounding tissue. Injection parameters can be tailored to individual experiments by adjusting the animal age at injection, injection location, volume of injection, rate of injection, AAV serotype and the promoter driving gene expression. Depending on the conditions chosen, virally-induced transgene expression can allow visualization of groups of cells, individual cells or fine cellular processes, down to the level of dendritic spines. The experiment shown here depicts an injection of double-stranded AAV expressing green fluorescent protein for the labeling of neurons and glia in the mouse primary visual cortex.
[1]
A. Majewska,et al.
Rapid, long‐term labeling of cells in the developing and adult rodent visual cortex using double‐stranded adeno‐associated viral vectors
,
2009,
Developmental neurobiology.
[2]
K. Jooss,et al.
Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.
,
2006,
Human gene therapy.
[3]
R. Chen,et al.
Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression.
,
1999,
Human gene therapy.
[4]
Donald W. Pfaff,et al.
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
,
1994,
Nature Genetics.